{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:22:06Z","timestamp":1794036126506,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"EUVIRNA","award":["264286"],"award-info":[{"award-number":["264286"]}]},{"name":"SILVER","award":["260644"],"award-info":[{"award-number":["260644"]}]},{"name":"Ministry of Science and Technology of R.O.C.","award":["NSC 103-2923-I-008-001"],"award-info":[{"award-number":["NSC 103-2923-I-008-001"]}]},{"name":"Ministry of Science and Technology of R.O.C.","award":["MOST 103-2113-M-007-018-MY3"],"award-info":[{"award-number":["MOST 103-2113-M-007-018-MY3"]}]},{"DOI":"10.13039\/501100005319","name":"National Central University, Taiwan","doi-asserted-by":"crossref","award":["103G603-14"],"award-info":[{"award-number":["103G603-14"]}],"id":[{"id":"10.13039\/501100005319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.antiviral.2015.06.013","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T00:46:23Z","timestamp":1435020383000},"page":"39-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"special_numbering":"C","title":["Suramin inhibits chikungunya virus replication through multiple mechanisms"],"prefix":"10.1016","volume":"121","author":[{"given":"Irina C.","family":"Albulescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"van Hoolwerff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Wolters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Bottaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Nastruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih Chi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shwu-Chen","family":"Tsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jih Ru","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Snijder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn J.","family":"van Hemert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.06.013_b0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1006\/viro.1999.9723","article-title":"The polysulfonated compound suramin blocks adsorption and lateral difusion of herpes simplex virus type-1 in vero cells","volume":"258","author":"Aguilar","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.06.013_b0010","doi-asserted-by":"crossref","DOI":"10.1099\/vir.0.069690-0","article-title":"An in vitro assay to study chikungunya virus RNA synthesis and the mode of action of inhibitors","author":"Albulescu","year":"2014","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.06.013_b0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0166-3542(93)90022-B","article-title":"Selective inhibition of human cytomegalovirus replication by naphthalenedisulfonic acid derivatives","volume":"20","author":"Baba","year":"1993","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.06.013_b0020","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbrc.2014.09.113","article-title":"Suramin inhibits helicase activity of NS3 protein of dengue virus in a fluorescence-based high throughput assay format","volume":"453","author":"Basavannacharya","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2015.06.013_b0025","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0140-6736(85)90002-9","article-title":"Effects of suramin on HTLV-III\/LAV infection presenting as Kaposi\u2019s sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo","volume":"2","author":"Broder","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2015.06.013_b0030","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nm0897-866","article-title":"Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate","volume":"3","author":"Chen","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2015.06.013_b0035","doi-asserted-by":"crossref","first-page":"16038","DOI":"10.1073\/pnas.1111650108","article-title":"Arbovirus high fidelity variant loses fitness in mosquitoes and mice","volume":"108","author":"Coffey","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.antiviral.2015.06.013_b0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0923-2516(97)89132-7","article-title":"Inhibition of sandfly fever Sicilian virus (Phlebovirus) replication in vitro by antiviral compounds","volume":"148","author":"Crance","year":"1997","journal-title":"Res. Virol."},{"key":"10.1016\/j.antiviral.2015.06.013_b0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3835(79)90017-X","article-title":"Suramin: a potent inhibitor of the reverse transcriptase of RNA tumor viruses","volume":"8","author":"De Clercq","year":"1979","journal-title":"Cancer Lett."},{"key":"10.1016\/j.antiviral.2015.06.013_b0050","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/med.20149","article-title":"Antiviral drug discovery: ten more compounds, and ten more stories (part B)","volume":"29","author":"De Clercq","year":"2009","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2015.06.013_b0055","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/med.21340","article-title":"Curious discoveries in antiviral drug development: the role of serendipity","volume":"35","author":"De Clercq","year":"2015","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2015.06.013_b0060","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/jac\/dku209","article-title":"Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral","volume":"69","author":"Delang","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2015.06.013_b0065","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1128\/AAC.03595-14","article-title":"Inhibition of Rift Valley fever virus replication and perturbation of nucleocapsid-RNA interactions by suramin","volume":"58","author":"Ellenbecker","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.06.013_b0070","doi-asserted-by":"crossref","first-page":"10877","DOI":"10.1128\/JVI.00949-10","article-title":"Chikungunya virus nonstructural protein 2 inhibits type I\/II interferon-stimulated JAK-STAT signaling","volume":"84","author":"Fros","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.06.013_b0075","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1096-9071(199903)57:3<238::AID-JMV5>3.0.CO;2-G","article-title":"Suramin blocks hepatitis C binding to human hepatoma cells in vitro","volume":"57","author":"Garson","year":"1999","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2015.06.013_b0080","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1099\/0022-1317-81-2-451","article-title":"Interactions of bovine viral diarrhoea virus glycoprotein E(rns) with cell surface glycosaminoglycans","volume":"81","author":"Iqbal","year":"2000","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.06.013_b0085","doi-asserted-by":"crossref","first-page":"6829","DOI":"10.1128\/JVI.00672-13","article-title":"Structure of severe fever with thrombocytopenia syndrome virus nucleocapsid protein in complex with suramin reveals therapeutic potential","volume":"87","author":"Jiao","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.06.013_b0090","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0002-9343(87)90108-2","article-title":"Lack of response to suramin in patients with AIDS and AIDS-related complex","volume":"82","author":"Kaplan","year":"1987","journal-title":"Am. J. Med."},{"key":"10.1016\/j.antiviral.2015.06.013_b0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/157488411796151174","article-title":"Tissue protective and anti-fibrotic actions of suramin: new uses of an old drug","volume":"6","author":"Liu","year":"2011","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.antiviral.2015.06.013_b0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jmv.1890210113","article-title":"Suramin treatment for chronic active hepatitis B\u2013toxic and ineffective","volume":"21","author":"Loke","year":"1987","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2015.06.013_b0105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jmb.2012.03.008","article-title":"Structure-based inhibition of Norovirus RNA-dependent RNA polymerases","volume":"419","author":"Mastrangelo","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2015.06.013_b0110","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/cmdc.201300563","article-title":"Delivery of suramin as an antiviral agent through liposomal systems","volume":"9","author":"Mastrangelo","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.antiviral.2015.06.013_b0115","doi-asserted-by":"crossref","first-page":"8607","DOI":"10.1093\/nar\/gks623","article-title":"Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays","volume":"40","author":"Mukherjee","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2015.06.013_b0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1432-1033.1988.tb13893.x","article-title":"Differential inhibition of various deoxyribonucleic and ribonucleic acid polymerases by suramin","volume":"172","author":"Ono","year":"1988","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.antiviral.2015.06.013_b0125","first-page":"385","article-title":"Suramin inhibits in vitro infection by duck hepatitis B virus, Rous sarcoma virus, and hepatitis delta virus","volume":"167","author":"Petcu","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.06.013_b0130","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1038\/emi.2014.60","article-title":"The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo","volume":"3","author":"Ren","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.antiviral.2015.06.013_b0135","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0042-6822(90)90440-3","article-title":"Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1","volume":"175","author":"Schols","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.06.013_b0140","doi-asserted-by":"crossref","first-page":"e71047","DOI":"10.1371\/journal.pone.0071047","article-title":"Characterization of synthetic Chikungunya viruses based on the consensus sequence of recent E1\u2013226V isolates","volume":"8","author":"Scholte","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2015.06.013_b0145","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1128\/JVI.03612-14","article-title":"Stress granule components G3BP1 and G3BP2 play a proviral role early in chikungunya virus replication","volume":"89","author":"Scholte","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.06.013_b0150","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/hep.21896","article-title":"Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans","volume":"46","author":"Schulze","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2015.06.013_b0155","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1128\/JVI.78.8.3817-3826.2004","article-title":"Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane","volume":"78","author":"Tamura","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2015.06.013_b0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2013.11.016","article-title":"Naphthalene-sulfonate inhibitors of human norovirus RNA-dependent RNA-polymerase","volume":"102","author":"Tarantino","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.06.013_b0165","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.antiviral.2013.06.009","article-title":"Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy","volume":"99","author":"Thiberville","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.06.013_b0170","doi-asserted-by":"crossref","first-page":"e1000054","DOI":"10.1371\/journal.ppat.1000054","article-title":"SARS-coronavirus replication\/transcription complexes are membrane-protected and need a host factor for activity in vitro","volume":"4","author":"van Hemert","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2015.06.013_b0175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0031-6997(25)00445-4","article-title":"Recent research on the biological activity of suramin","volume":"45","author":"Voogd","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.antiviral.2015.06.013_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2013.12.008","article-title":"Suramin inhibits EV71 infection","volume":"103","author":"Wang","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2015.06.013_b0185","doi-asserted-by":"crossref","first-page":"e2921","DOI":"10.1371\/journal.pntd.0002921","article-title":"Arrival of chikungunya virus in the new world: prospects for spread and impact on public health","volume":"8","author":"Weaver","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2015.06.013_b0190","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMra1406035","article-title":"Chikungunya virus and the global spread of a mosquito-borne disease","volume":"372","author":"Weaver","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215001448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T16:15:10Z","timestamp":1748448910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215001448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":38,"alternative-id":["S0166354215001448"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.06.013","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725592547.793539883","asserted-by":"object"}]},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suramin inhibits chikungunya virus replication through multiple mechanisms","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}